Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Former Fed Chair Alan Greenspan dies at 100
• Qtrex Quantum executives plan to buy up to 2M shares over 12 months
• Onto Innovation Inc. (ONTO) PT Raised to $450 at Oppenheimer